{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:22:30Z","timestamp":1794327750076,"version":"4.9.0"},"reference-count":32,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives\/Background<\/jats:title>\n                    <jats:p>Our objective was to assess the short\u2010term treatment response and tolerability of mirogabalin in patients with trigeminal neuralgia. Trigeminal neuralgia is a debilitating neuropathic pain disorder for which carbamazepine is the first\u2010line therapy; however, this treatment is often limited by adverse effects. Mirogabalin, the third and most recently developed gabapentinoid, has demonstrated analgesic benefit with an acceptable safety profile in peripheral neuropathic pain conditions; however, its clinical role in trigeminal neuralgia remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective, open\u2010label, single\u2010arm observational pilot study at a single tertiary referral center in Japan between July 2021 and May 2025, enrolling 21 patients with trigeminal neuralgia, with pre\u2010 and postassessment of pain outcomes over a 3\u2010month follow\u2010up period. Pain intensity was assessed using the Numerical Rating Scale at baseline and at 1 and 3\u2009months after treatment initiation. Responder rates and adverse events were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median Numerical Rating Scale score decreased from 6 (interquartile range [IQR], 6\u20138) at baseline to 2 (IQR, 2\u20134) at 1\u2009month and 1 (IQR, 0\u20132) at 3\u2009months (Friedman test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). At 1\u2009month, 20 out of 21 patients (95%) achieved a \u22652\u2010point reduction, and all evaluable patients (20 out of 20) met this threshold at 3\u2009months. Response rates for \u226570% improvement increased from 6 out of 21 (29%) at 1\u2009month to 14 out of 20 (70%) at 3\u2009months (McNemar test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). No patients discontinued treatment because of adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this prospective, single\u2010arm pilot study, mirogabalin was associated with short\u2010term reductions in pain intensity and appeared to be generally well tolerated in patients with trigeminal neuralgia. These findings are hypothesis\u2010generating and require confirmation in larger, controlled, and longer\u2010term randomized trials to test the efficacy and safety of mirogabalin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.70134","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:30:00Z","timestamp":1782394200000},"page":"2371-2379","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain reduction and tolerability of mirogabalin in trigeminal neuralgia: A prospective observational study"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-5724","authenticated-orcid":false,"given":"Hiroaki","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9993-1685","authenticated-orcid":false,"given":"Akihiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomogane","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuya","family":"Yamaura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cerebrovascular Research Institute Yoshida Hospital  Kobe Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.90a.22052"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102606"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/papr.70051"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3934\/mbe.2024235"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.5455\/msm.2015.27.167-171"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1727"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.22514\/jofph.2025.011"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14505"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1045640"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69258"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082315"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14952"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00068-7"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S407543"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2021.34.1.4"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13013"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001501"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1491570"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.4317\/jced.61552"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2024.12.015"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418791818"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229228"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16060737"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13447-9"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5943"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.05.004"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.12.014"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.205"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.11321\/jjspc.24-0061"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.70134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.70134","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.70134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:28:14Z","timestamp":1794324494000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.70134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1111\/head.70134"],"URL":"https:\/\/doi.org\/10.1111\/head.70134","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"2026-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}